Filing Details

Accession Number:
0001209191-20-038919
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-25 16:32:56
Reporting Period:
2020-06-23
Accepted Time:
2020-06-25 16:32:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808158 Repare Therapeutics Inc. RPTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1473930 Todd Foley C/O Mpm Capital
450 Kendall Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2020-06-23 1,801,581 $0.00 1,801,581 No 4 C Indirect See Footnote
Common Shares Acquisiton 2020-06-23 952,191 $0.00 2,753,772 No 4 C Indirect See Footnote
Common Shares Acquisiton 2020-06-23 250,000 $20.00 3,003,772 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Class A Preferred Shares Disposition 2020-06-23 1,801,581 $0.00 1,801,581 $0.00
Common Shares Class B Preferred Shares Disposition 2020-06-23 952,191 $0.00 952,191 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. All series of convertible preferred shares converted into the number of shares of the Issuer's common shares on a 1-for-1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
  2. The shares are held as follows: 1,636,136 by MPM BioVentures 2014, L.P. ("BV 2014"), 109,128 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 56,317 by MPM Asset Management Investors BV2014 LLC ("AM BV2014"). MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). Todd Foley is a managing director of BV LLC and a member of AM BV2014.
  3. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  4. The shares are held as follows: 2,500,885 by BV 2014, 166,805 by BV 2014(B) and 86,082 by AM BV2014.
  5. The shares were purchased as follows: 227,042 by BV 2014, 15,143 by BV 2014(B) and 7,815 by AM BV2014.
  6. The shares are held as follows: 2,727,927 by BV 2014, 181,948 by BV 2014(B) and 93,897 by AM BV2014.
  7. No securities held by the Reporting Person.